FDA approves Alexion’s Ultomiris for another rare blood disease - Abilitify

October 21, 2019 abilitify 0 Comments

The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals’ treatment for a second rare blood disorder, the company said.

Tags: crm erp Startups